Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Narayana Hrudaya
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,222 | 1,233 | 1,305 | 1,204 | 1,246 | 1,306 | 1,367 | 1,335 | 1,475 | 1,507 | 1,644 | 2,151 | 2,594 |
| Expenses + | 946 | 963 | 997 | 925 | 955 | 1,004 | 1,058 | 1,027 | 1,118 | 1,171 | 1,243 | 1,786 | 2,086 |
| Operating Profit | 276 | 271 | 308 | 279 | 291 | 302 | 309 | 307 | 358 | 337 | 401 | 365 | 508 |
| OPM % | 23% | 22% | 24% | 23% | 23% | 23% | 23% | 23% | 24% | 22% | 24% | 17% | 20% |
| Other Income + | 15 | 15 | 18 | 18 | 26 | 24 | 23 | 18 | 20 | 24 | 24 | -29 | 25 |
| Interest | 21 | 21 | 23 | 25 | 28 | 34 | 35 | 37 | 41 | 45 | 42 | 65 | 91 |
| Depreciation | 56 | 59 | 55 | 63 | 65 | 61 | 65 | 70 | 82 | 84 | 87 | 122 | 154 |
| Profit before tax | 214 | 206 | 248 | 209 | 225 | 231 | 232 | 219 | 254 | 232 | 296 | 149 | 288 |
| Tax % | 19% | 11% | 9% | 10% | 15% | 13% | 14% | 12% | 22% | 15% | 13% | 15% | 22% |
| Net Profit + | 173 | 184 | 227 | 188 | 191 | 202 | 199 | 193 | 197 | 197 | 258 | 127 | 224 |
| EPS in Rs | 8.47 | 9.00 | 11.09 | 9.20 | 9.33 | 9.85 | 9.72 | 9.44 | 9.65 | 9.62 | 12.64 | 6.20 | 10.96 |
Financials of Narayana Hrudaya
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,364 | 1,614 | 1,878 | 2,281 | 2,861 | 3,128 | 2,583 | 3,701 | 4,525 | 4,890 | 5,483 | 7,896 |
| Expenses + | 1,236 | 1,434 | 1,642 | 2,064 | 2,566 | 2,694 | 2,394 | 3,038 | 3,538 | 3,722 | 4,185 | 6,285 |
| Operating Profit | 128 | 180 | 236 | 217 | 295 | 434 | 189 | 664 | 987 | 1,168 | 1,298 | 1,611 |
| OPM % | 9% | 11% | 13% | 10% | 10% | 14% | 7% | 18% | 22% | 24% | 24% | 20% |
| Other Income + | 6 | -19 | 7 | 18 | 16 | 7 | 21 | 26 | 59 | 73 | 80 | 45 |
| Interest | 45 | 33 | 28 | 55 | 81 | 94 | 82 | 76 | 84 | 112 | 163 | 244 |
| Depreciation | 68 | 76 | 80 | 100 | 137 | 186 | 184 | 183 | 210 | 241 | 278 | 448 |
| Profit before tax | 21 | 51 | 135 | 80 | 93 | 161 | -56 | 430 | 752 | 888 | 936 | 964 |
| Tax % | 71% | 59% | 39% | 36% | 37% | 26% | -75% | 20% | 19% | 11% | 16% | 16% |
| Net Profit + | -19 | 21 | 83 | 51 | 59 | 119 | -14 | 342 | 607 | 790 | 791 | 806 |
| EPS in Rs | -0.84 | 1.04 | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.66 | 39.42 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 35% | 17% | 0% | 6% | 8% | 10% | 12% | 11% |
Financials of Narayana Hrudaya
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
| Reserves | 568 | 672 | 759 | 831 | 877 | 932 | 916 | 1,284 | 1,927 | 2,679 | 3,422 | 4,333 |
| Borrowings + | 362 | 258 | 217 | 802 | 813 | 952 | 826 | 723 | 884 | 1,627 | 2,428 | 5,857 |
| Other Liabilities + | 241 | 424 | 468 | 692 | 746 | 813 | 833 | 931 | 1,155 | 1,123 | 1,216 | 2,080 |
| Total Liabilities | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 12,474 |
| Fixed Assets + | 913 | 1,054 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 | 4,266 | 7,821 |
| CWIP | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 | 86 | 267 |
| Investments | 52 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 | 1,084 | 573 |
| Other Assets + | 385 | 402 | 417 | 637 | 729 | 711 | 678 | 964 | 1,323 | 1,624 | 1,835 | 3,813 |
| Total Assets | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 12,474 |
Financials of Narayana Hrudaya
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 | 986 | 1,621 |
| Cash from Investing Activity + | -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 | -1,325 | -3,700 |
| Cash from Financing Activity + | 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 488 | 544 | 2,340 |
| Net Cash Flow | -6 | 42 | 28 | -22 | 89 | 7 | -2 | 59 | -4 | 97 | 205 | 262 |
| Free Cash Flow | -15 | 86 | 85 | -20 | 129 | 329 | 235 | 235 | 563 | 99 | -93 | 753 |
| CFO/OP | 78% | 116% | 108% | 100% | 113% | 117% | 133% | 83% | 119% | 99% | 86% | 110% |
Financials of Narayana Hrudaya
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 34 | 30 | 45 | 34 | 31 | 39 | 43 | 35 | 31 | 37 | 30 |
| Inventory Days | 56 | 48 | 45 | 56 | 48 | 35 | 32 | 30 | 31 | 44 | 40 | 37 |
| Days Payable | 146 | 152 | 173 | 200 | 177 | 177 | 221 | 180 | 224 | 214 | 185 | 248 |
| Cash Conversion Cycle | -51 | -70 | -98 | -100 | -95 | -111 | -150 | -108 | -158 | -138 | -108 | -181 |
| Working Capital Days | -30 | -12 | -11 | -10 | -10 | -22 | -38 | -16 | -25 | -30 | -17 | -1 |
| ROCE % | 7% | 9% | 14% | 9% | 9% | 14% | 2% | 25% | 32% | 26% | 21% | 15% |
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…
Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…